Side-effect-driven discontinuation and how visibility addresses it
A whitepaper on why manageable side effects end treatment, and how a structured between-visit record changes the outcome.
Side effects are among the most common reasons patients stop chronic therapy. Most are manageable. The problem is that they often go unrecorded until the patient has already decided to quit.
The pattern
Early side effects tend to cluster after dose changes and ease with time and support. Without a record, the patient experiences each hard day in isolation and the clinician never sees the trend.
What visibility changes
When side effects are logged with timing and severity, the rhythm becomes clear. An expected adjustment can be distinguished from a real problem. The patient gets reassurance, and the clinician gets an early warning.
Boundaries
This is a documentation and communication tool. It does not treat side effects or replace clinical judgment. Its value is making the experience visible in time to act.
The opportunity
Much side-effect-driven discontinuation is avoidable. Visibility between visits is a direct and practical way to address it.